Nalawade SA[au] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2018	1
2019	1
2021	1
2022	0

Page 1

Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer.

Nalawade SA, Shafer P, Bajgain P, McKenna MK, Ali A, Kelly L, Joubert J, Gottschalk S, Watanabe N, Leen A, Parihar R, Vera Valdes JF, Hoyos V. Nalawade SA, et al. J Immunother Cancer. 2021 Nov;9(11):e003237. doi: 10.1136/jitc-2021-003237. J Immunother Cancer. 2021. PMID: 34815355 Free PMC article.

Direct Transformation of N-Protected α,β-Unsaturated γ-Amino Amides into γ-Lactams through a Base-Mediated Molecular Rearrangement.

Ganesh Kumar M, Veeresh K, Nalawade SA, Nithun RV, Gopi HN. Ganesh Kumar M, et al. Among authors: nalawade sa. J Org Chem. 2019 Dec 6;84(23):15145-15153. doi: 10.1021/acs.joc.9b01936. Epub 2019 Nov 11. J Org Chem. 2019. PMID: 31657563

Aire is not essential for regulating neuroinflammatory disease in mice transgenic for human autoimmune-diseases associated MHC class II genes HLA-DR2b and HLA-DR4.

Nalawade SA, Ji N, Raphael I, Pratt A 3rd, Kraig E, Forsthuber TG. Nalawade SA, et al. Cell Immunol. 2018 Sep;331:38-48. doi: 10.1016/j.cellimm.2018.05.003. Epub 2018 May 14. Cell Immunol. 2018. PMID: 29789121 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results